Sernova Corp. (TSE:SVA – Get Free Report)’s stock price fell 2.9% during trading on Thursday . The company traded as low as C$0.17 and last traded at C$0.17. 135,769 shares changed hands during mid-day trading, a decline of 10% from the average session volume of 151,625 shares. The stock had previously closed at C$0.17.
Sernova Stock Performance
The stock has a market capitalization of C$55.52 million, a price-to-earnings ratio of -1.59 and a beta of 1.35. The company has a quick ratio of 18.11, a current ratio of 0.32 and a debt-to-equity ratio of -4.40. The stock’s 50-day simple moving average is C$0.19 and its 200 day simple moving average is C$0.20.
About Sernova
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.
See Also
- Five stocks we like better than Sernova
- Differences Between Momentum Investing and Long Term Investing
- Is Meta Plotting a Stablecoin Comeback Years After Libra’s Flop?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Silver’s Options Sizzle: Are Traders Betting on a Breakout?
- Following Congress Stock Trades
- AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio?
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
